TABLE 5

Clinical Scenarios for the Use of Stress Perfusion PET in the Evaluation of Arrhythmias Without Ischemic Equivalent (No Prior Cardiac Evaluation)

Scenario no.	Description	Appropriateness	Score
Clinically stable patients with sustained VT
56	Clinically stable patients with an episode of sustained VT who have a low global clinical risk of CAD	May be Appropriate	6
57	Clinically stable patients with an episode of sustained VT who have an intermediate clinical risk of CAD	Appropriate	9
58	Clinically stable patients with an episode of sustained VT who have a high clinical risk of CAD	Appropriate	8
59	Clinically unstable patients with an episode of sustained VT	Rarely Appropriate	1
Patients with a recent episode of VF
60	Clinically stable patients with a recent episode of VF who have a low clinical risk of CAD	Rarely Appropriate	1
61	Clinically unstable patients with a recent episode of VF	Rarely Appropriate	1
Patients with exercise-induced VT or nonsustained VT
62	Patients with nonsustained VT who have a low clinical risk of CAD	May be Appropriate	4
63	Patients with exercise-induced VT who have a low clinical risk of CAD	May be Appropriate	5
64	Patients with nonsustained VT who have an intermediate clinical risk of CAD	Appropriate	7
65	Patients with exercise-induced VT who have an intermediate clinical risk of CAD	Appropriate	8
66	Patients with nonsustained VT who have a high clinical risk of CAD	Appropriate	8
67	Patients with exercise-induced VT who have a high clinical risk of CAD	May be Appropriate	4
Patients with frequent PVCs
68	Patients with frequent PVCs who have a low clinical risk of CAD	Appropriate	7
69	Patients with frequent PVCs who have an intermediate clinical risk of CAD	Appropriate	8
70	Patients with frequent PVCs who have a high clinical risk of CAD	Rarely Appropriate	2
Patients with infrequent PVCs
71	Patients with infrequent PVCs who have a low clinical risk of CAD	Rarely Appropriate	1
72	Patients with infrequent PVCs who have an intermediate clinical risk of CAD	May be Appropriate	5
73	Patients with infrequent PVCs who have a high clinical risk of CAD	May be Appropriate	5
Patients with new-onset AF
74	Patients with new-onset AF who have a low global clinical risk of CAD	Rarely Appropriate	2
75	Patients with new-onset AF who have an intermediate global clinical risk of CAD	May be Appropriate	5
76	Patients with new-onset AF who have a high global clinical risk of CAD	May be Appropriate	6
Evaluation of patients before the initiation of antiarrhythmic medications
77	Patients with a low global CAD risk before initiation of antiarrhythmic medications	May be Appropriate	5
78	Patients with an intermediate global CAD risk before initiation of antiarrhythmic medications	May be Appropriate	6
79	Patients with a high global CAD risk before initiation of antiarrhythmic medications	Appropriate	7